
Market Rally Aims for “Cloud Nine,” Bronfman's Paramount Bid, Eli Lilly CEO on Weight-Loss Drug 8/20/24
Squawk on the Street
00:00
Revolutionizing Weight Loss and Health
This chapter discusses the recent breakthroughs in weight-loss medications, focusing on Eli Lilly's drug and its effectiveness for managing pre-diabetes. Significant outcomes from a comprehensive study are highlighted, showcasing weight loss and reduced diabetes conversion rates. Additionally, the chapter explores the competitive pharmaceutical landscape and advocates for improved insurance coverage for obesity treatments, addressing the critical health implications for patients.
Play episode from 34:18
Transcript


